Profile
Anthony M.
Rimac held several financial and administrative positions in various companies, including Director of Financial Planning & Analysis at Aradigm Corp., Vice President of Finance at Artemis Medical, Inc., Chief Financial Officer & Senior Vice President at Aerovance, Inc., Chief Financial Officer at Chrono Therapeutics, Inc., Chief Financial Officer at Adamas Pharmaceuticals LLC, Chief Financial Officer at Aldea Pharmaceuticals, Inc., and Vice President of Finance & Administration at Aesculap, Inc. Rimac also served as the Chief Operating, Financial & Accounting Officer at Sagimet Biosciences, Inc. and Chief Financial Officer at ESCAPE Bio, Inc. Rimac earned an MBA from Santa Clara University and an undergraduate degree from the University of California, Santa Barbara.
Former positions of Anthony Rimac
| Companies | Position | End |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director of Finance/CFO | 30/01/2024 |
Aldea Pharmaceuticals, Inc.
 Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Director of Finance/CFO | 30/06/2015 |
| ADAMAS PHARMACEUTICALS, INC. | Director of Finance/CFO | 12/08/2014 |
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology ESCAPE Bio, Inc. is a preclinical stage biopharmaceutical company. It focuses on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. The company was founded by Robert Mahley and Yadong Huang in 2015 and is headquartered in San Francisco, CA. | Director of Research - Equity | - |
Chrono Therapeutics, Inc.
 Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | Director of Finance/CFO | - |
Training of Anthony Rimac
| University of California, Santa Barbara | Undergraduate Degree |
| Santa Clara University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| Private companies | 8 |
|---|---|
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
Artemis Medical, Inc.
 Artemis Medical, Inc. Medical SpecialtiesHealth Technology Artemis Medical, Inc. engages in the marketing and sale of biopsy markers. The company was founded by Richard Fulton and is headquartered in Cincinnati, OH. | Health Technology |
Aesculap, Inc.
 Aesculap, Inc. Medical SpecialtiesHealth Technology Aesculap, Inc. manufactures surgical instruments. It offers neurosurgery, power systems, surgical instruments, vet care, and wound closure. The firm services include surgical instrument and equipment repair, surgical asset management, and instrument tracking software. The company founded by Gottfried Jetter in 1867 and is headquartered in Center Valley, PA. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | Commercial Services |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology ESCAPE Bio, Inc. is a preclinical stage biopharmaceutical company. It focuses on the discovery and development of therapies to treat genetically defined, neurodegenerative diseases. The company was founded by Robert Mahley and Yadong Huang in 2015 and is headquartered in San Francisco, CA. | Health Technology |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Anthony Rimac
